J E Swartz1, M C J Aarts1,2, K M A Swart1,3, J J Disa4, M Gerressen5,6, Y-R Kuo7, M K Wax8, W Grolman1,3, W W Braunius1. 1. Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Otorhinolaryngology, Jeroen Bosch Hospital, Den Bosch, The Netherlands. 3. Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht, the Netherlands. 4. Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 5. Department of Oral, Maxillofacial and Plastic Facial Surgery, Heinrich Braun Hospital, Zwickau, Germany. 6. Department of Oral, Maxillofacial and Plastic Facial Surgery, University Hospital of the Aachen University (RWTH), Aachen, Germany. 7. Department of Plastic and Reconstructive Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. 8. Department of Otolaryngology-HNS, Oregon Health and Sciences University, Portland, OR, USA.
Abstract
BACKGROUND: Free radial forearm flap (FRFF) reconstruction is a valuable technique in head and neck surgery, which allows closure of large defects while striving to maintain functionality. Anticoagulative drugs are often administered to improve flap survival, although evidence regarding effectiveness is lacking. OBJECTIVE OF REVIEW: To investigate the effectiveness of postoperative anticoagulants to improve survival of the FRFF in head and neck reconstruction. TYPE OF REVIEW: Systematic review and multicentre, individual patient data meta-analysis. SEARCH STRATEGY: MEDLINE, EMBASE, Web of Science and CINAHL were searched for synonyms of 'anticoagulants' and 'free flap reconstruction'. EVALUATION METHOD: Studies were critically appraised for directness of evidence and risk of bias. Authors of the highest quality publications were invited to submit their original data for meta-analysis. RESULTS: Five studies were of adequate quality, and data from four studies (80%) were available for meta-analysis, describing 759 FRFF procedures. Anticoagulants used were as follows: aspirin (12%), low molecular weight dextran (18.3%), unfractioned heparin (28.1%), low molecular weight heparin (49%) and prostaglandin-E1 (2.1%). Thirty-one per cent did not receive anticoagulants. Flap failure occurred in 40 of 759 patients (5.3%) On univariate analysis, use of unfractioned heparin was associated with a higher rate of flap failure. However, these regimens were often administered to patients who had revision surgery of the anastomosis. In multivariate logistic regression analysis, anticoagulant use was not associated with improved flap survival or flap-related complications. CONCLUSIONS: The studied anticoagulative drugs did not improve FRFF survival or lower the rate of flap-related complications. In addition, some anticoagulants may cause systemic complications.
BACKGROUND: Free radial forearm flap (FRFF) reconstruction is a valuable technique in head and neck surgery, which allows closure of large defects while striving to maintain functionality. Anticoagulative drugs are often administered to improve flap survival, although evidence regarding effectiveness is lacking. OBJECTIVE OF REVIEW: To investigate the effectiveness of postoperative anticoagulants to improve survival of the FRFF in head and neck reconstruction. TYPE OF REVIEW: Systematic review and multicentre, individual patient data meta-analysis. SEARCH STRATEGY: MEDLINE, EMBASE, Web of Science and CINAHL were searched for synonyms of 'anticoagulants' and 'free flap reconstruction'. EVALUATION METHOD: Studies were critically appraised for directness of evidence and risk of bias. Authors of the highest quality publications were invited to submit their original data for meta-analysis. RESULTS: Five studies were of adequate quality, and data from four studies (80%) were available for meta-analysis, describing 759 FRFF procedures. Anticoagulants used were as follows: aspirin (12%), low molecular weight dextran (18.3%), unfractioned heparin (28.1%), low molecular weight heparin (49%) and prostaglandin-E1 (2.1%). Thirty-one per cent did not receive anticoagulants. Flap failure occurred in 40 of 759 patients (5.3%) On univariate analysis, use of unfractioned heparin was associated with a higher rate of flap failure. However, these regimens were often administered to patients who had revision surgery of the anastomosis. In multivariate logistic regression analysis, anticoagulant use was not associated with improved flap survival or flap-related complications. CONCLUSIONS: The studied anticoagulative drugs did not improve FRFF survival or lower the rate of flap-related complications. In addition, some anticoagulants may cause systemic complications.
Authors: Joseph J Disa; Virginia P Polvora; Andrea L Pusic; Bhuvinesh Singh; Peter G Cordeiro Journal: Plast Reconstr Surg Date: 2003-11 Impact factor: 4.730
Authors: Constance M Chen; Peter Ashjian; Joseph J Disa; Peter G Cordeiro; Andrea L Pusic; Babak J Mehrara Journal: Plast Reconstr Surg Date: 2008-03 Impact factor: 4.730
Authors: Michel Saint-Cyr; Corrine Wong; Edward W Buchel; Shannon Colohan; William C Pederson Journal: Plast Reconstr Surg Date: 2012-12 Impact factor: 4.730
Authors: Nick Spindler; Philipp Pieroh; Ulrich Spiegl; Sergey Arakelyan; Johannes Karl Maria Fakler; Christoph-Eckhard Heyde; Stefan Langer Journal: Clin Interv Aging Date: 2021-03-18 Impact factor: 4.458
Authors: Fatima Barhoum; Klaus Tschaikowsky; Michael Koch; Markus Kapsreiter; Matti Sievert; Sarina Müller; Miguel Goncalves; Maximilian Traxdorf; Claudia Scherl Journal: Int J Surg Case Rep Date: 2020-09-18